[Featured Stock] CareLabs, Remote Medical Care Activated Due to COVID-19... App Downloads Rank No.1

[Asia Economy Reporter Hyunseok Yoo] As the spread of the novel coronavirus infection (COVID-19) accelerates the transition to an 'untact' (contactless) society, expectations for growth in the remote medical care sector are increasing. This is why the stock price of CareLabs, the number one mobile healthcare platform company, is showing strength.

As of 11:01 AM on the 9th, CareLabs was trading at 18,550 KRW, up 3.92% (700 KRW) compared to the previous trading day.

With the steady occurrence of COVID-19 confirmed cases recently, the government temporarily eased regulations on remote medical care. A new quarantine measure was introduced allowing patients to receive consultations and prescriptions over the phone without visiting medical institutions in person.

CareLabs started the country's first pilot remote medical service in cooperation with 133 hospitals and clinics through the GoodDoc app.

GoodDoc's remote medical service is a mobile remote medical care service that enables everything from hospital reservations to consultations, prescription issuance, and payment of medical fees.

CareLabs ranked first in total App Store downloads for the month of March with GoodDoc's non-face-to-face remote medical service, CoronaScanner which provides real-time movement paths of COVID-19 confirmed cases, and MaskScanner which allows real-time checking of public mask inventory.

CareLabs expects its value as the number one mobile healthcare platform to grow further by successfully providing the first practical and effective non-face-to-face healthcare service in Korea.

This content was produced with the assistance of AI translation services.